April 5, 2022
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a…
March 15, 2022
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…
February 17, 2021
Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…
October 13, 2020
Saladax Hires 8 to Address Demand for Schizophrenia Medication Test
Saladax Biomedical, Inc., Ben Franklin TechVentures, Bethlehem, has expanded its staff with eight new employees in…
July 8, 2020
Saladax Biomedical launches clozapine test in the US after FDA grants market authorization
Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…
May 1, 2020
Saladax Biomedical launches clozapine test in the US after FDA grants market authorization
Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…
